Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Biochemical and Biophysical Research Communications|May 18, 1999
Interaction cloning and characterization of the cDNA encoding the human prenylated rab acceptor (PRA1)C Bucci, M Chiariello, D Lattero, et al.
Journal of Cell Science|June 1, 1994
Association of Rap1a and Rap1b proteins with late endocytic/phagocytic compartments and Rap2a with the Golgi complexV Pizon, M Desjardins, C Bucci, et al.
Biochemical and Biophysical Research Communications|December 24, 1996
Molecular cloning and expression analysis of the human Rab7 GTP-ase complementary deoxyribonucleic acidR Vitelli, M Chiariello, D Lattero, et al.
Molecular Biology of the Cell|February 26, 2000
Rab7: a key to lysosome biogenesisC Bucci, P Thomsen, P Nicoziani, et al.
Biochemical and Biophysical Research Communications|August 15, 1998
Control of Rab5 and Rab7 expression by the isoprenoid pathwayC Laezza, C Bucci, M Santillo, et al.
Gastroenterology Research and Practice|May 4, 2018
Prevalence of Sleep Bruxism in IBD Patients and Its Correlation to Other Dental Disorders and Quality of LifeC Bucci, M Amato, F Zingone, et al.
Molecular Microbiology|July 20, 1999
Intracistronic transcription termination in polysialyltransferase gene (siaD ) affects phase variation in Neisseria meningitidisA Lavitola, C Bucci, P Salvatore, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 22, 2011
Predictors of new and severe vertebral fractures: results from the HORIZON Pivotal Fracture TrialR Wustrack, E Seeman, C Bucci-Rechtweg, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
Rab5a is a common component of the apical and basolateral endocytic machinery in polarized epithelial cellsC Bucci, A Wandinger-Ness, A Lütcke, et al.
Techniques in Coloproctology|August 8, 2013
A pilot study on the effect of a symbiotic mixture in irritable bowel syndrome: an open-label, partially controlled, 6-month extension of a previously published trialC Bucci, F Tremolaterra, S Gallotta, et al.
Pageof 10